Treat-to-target in the management of moderate-to-severe atopic dermatitis in adults: A Canadian perspective-Reference-Cited by-同舟云学术

Treat-to-target in the management of moderate-to-severe atopic dermatitis in adults: A Canadian perspective

Published:2023-08 Issue:2 Volume:89 Page:372-375
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Yeung Jensen,Gooderham Melinda J.,Hong H. Chih-Ho,Lynde Charles,Prajapati Vimal H.,Lansang Perla,Turchin Irina,Wiseman Marni,Jack Carolyn,Ramien Michele,Purdy Kerri,Grewal Parbeer

Publisher

Elsevier BV

Subject

Dermatology

Reference5 articles.

1. Treat-to-target in atopic dermatitis: an international consensus on a set of core decision points for systemic therapies;De Bruin-Weller;Acta Derm Venereol,2021

2. Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative);Chalmers;Br J Dermatol,2016

3. Atopic dermatitis: therapeutic care delivery: therapeutic education, shared decision-making, and access to care;LeBovidge;Semin Cutan Med Surg,2017

4. Therapeutic patient education in atopic dermatitis: worldwide experiences;Stalder;Pediatr Dermatol,2013

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 650 - Stability of long-term therapeutic responses to tralokinumab in adults with moderate-to-severe atopic dermatitis;British Journal of Dermatology;2024-08

2. Dupilumab in Patients with Atopic Dermatitis: A Multicentric, Long-Term, Real-World Portuguese Study;Dermatology and Therapy;2024-07-22

3. Combining treat‐to‐target principles and shared decision‐making: International expert consensus‐based recommendations with a novel concept for minimal disease activity criteria in atopic dermatitis;Journal of the European Academy of Dermatology and Venereology;2024-07-11

4. Targeted Combined Endpoint Improvement in Patient and Disease Domains in Atopic Dermatitis: A Treat-to-Target Analysis of Adults with Moderate-to-Severe Atopic Dermatitis Treated with Upadacitinib;Acta Dermato-Venereologica;2024-05-06

5. Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2);Dermatology and Therapy;2024-05